微针流感疫苗市场－全球产业规模、份额、趋势、机会和预测，依产品类型、疫苗类型、地区和竞争格局划分，2020-2030年预测

2024年全球微针流感疫苗市场规模为11.8亿美元，预计2030年将以5.96%的复合年增长率成长至16.7亿美元。全球微针流感疫苗是一种创新的给药系统，它利用通常整合在贴片中的微型针头，将流感疫苗注射到皮肤表层，为传统的肌肉注射提供了一种创伤较小的替代方案。该市场的成长主要受人们对无痛且可自行接种疫苗方式的需求不断增长的推动，旨在减少针头恐惧症并提高全球患者的依从性。

主要市场驱动因素

全球微针流感疫苗市场主要受以下因素影响：消费者对无痛、可自行接种疫苗的需求不断增长，以及微针技术的持续进步。人们希望以更微创的方式接种疫苗，这是推动市场发展的重要因素，有助于解决普遍存在的针头恐惧症，提高患者依从性，而这些因素历来是疫苗接种的障碍。

主要市场挑战

新型药物递送系统复杂而严格的监管审批流程，对全球微针流感疫苗市场的扩张构成了重大障碍。作为兼具医疗器材和生物製剂特性的产品，微针疫苗必须满足广泛而严格的临床试验要求。

主要市场趋势

可溶解微针技术的出现标誌着疫苗递送领域的一项显着进步，它避免了尖锐生物危害性废弃物的产生，从而提高了患者的舒适度和安全性。这些基于可生物降解聚合物的贴片可在皮肤内溶解，实现精准且持续的抗原释放，有助于提高疫苗效力，并有可能降低疫苗剂量。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球微针流感疫苗市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（实心微针、空心微针）
  • 依疫苗类型（三价流感疫苗、四价流感疫苗）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美微针流感疫苗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲微针流感疫苗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区微针流感疫苗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲微针流感疫苗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲微针流感疫苗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球微针流感疫苗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Debiotech SA
• NanoPass Technologies Limited
• Becton, Dickinson and Company
• FluGen, Inc.
• CosMED Pharmaceuticals Co., Ltd.
• Microdermics Inc.
• TSRL Inc.
• Vaxess Technologies Inc.
• Pfizer, Inc.
• Merck & Co., Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Microneedle Flu Vaccine Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 5.96% to reach USD 1.67 Billion by 2030. The global microneedle flu vaccine is an innovative delivery system utilizing microscopic needles, typically integrated into a patch, to administer the influenza vaccine into the superficial layers of the skin, offering a less invasive alternative to traditional intramuscular injections. This market's growth is primarily driven by the increasing demand for painless and self-administered vaccination methods, aiming to reduce needle phobia and enhance patient compliance globally.

Key Market Drivers

The global microneedle flu vaccine market is primarily influenced by the rising demand for painless and self-administered vaccination methods and continuous advancements in microneedle technology. The desire for less invasive vaccine delivery is a significant driver, addressing widespread needle phobia and improving patient compliance, which traditionally pose barriers to vaccination uptake. For instance, according to a study published in the *Journal of Multidisciplinary Healthcare*, in May 2024, "Prevalence, factors associated and management of needle phobia among the general population in Saudi Arabia and Egypt", approximately 36.5% of adult participants reported experiencing needle phobia, highlighting a substantial population that could benefit from alternative administration routes.

Key Market Challenges

The complex and stringent regulatory approval process for novel drug delivery systems presents a significant obstacle to the expansion of the global microneedle flu vaccine market. As products combining both a medical device and a biologic, microneedle vaccines are subject to extensive and rigorous requirements for clinical trials. These trials must rigorously demonstrate the safety, efficacy, and consistent manufacturing scalability of the integrated system.

Key Market Trends

The shift towards dissolvable microneedle technologies marks a notable advancement in vaccine delivery, offering enhanced patient comfort and safety by eliminating sharp biohazardous waste. These biodegradable polymer-based patches dissolve within the skin, facilitating precise and sustained antigen release, which can improve vaccine efficacy and potentially allow for reduced dosage requirements. This trend underscores the industry's commitment to innovation in materials science for medical applications.

Key Market Players

• Debiotech S.A.
• NanoPass Technologies Limited
• Becton, Dickinson and Company
• FluGen, Inc.
• CosMED Pharmaceuticals Co., Ltd.
• Microdermics Inc.
• TSRL Inc.
• Vaxess Technologies Inc.
• Pfizer, Inc.
• Merck & Co., Inc.

Report Scope:

In this report, the Global Microneedle Flu Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microneedle Flu Vaccine Market, By Product Type:

• Solid Microneedle
• Hollow Microneedle

Microneedle Flu Vaccine Market, By Vaccine Type:

• Trivalent Flu Vaccine
• Quadrivalent Flu Vaccine

Microneedle Flu Vaccine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Microneedle Flu Vaccine Market.

Available Customizations:

Global Microneedle Flu Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microneedle Flu Vaccine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
  • 5.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Microneedle Flu Vaccine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Vaccine Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microneedle Flu Vaccine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Vaccine Type
  • 6.3.2. Canada Microneedle Flu Vaccine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Vaccine Type
  • 6.3.3. Mexico Microneedle Flu Vaccine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Vaccine Type

7. Europe Microneedle Flu Vaccine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Vaccine Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microneedle Flu Vaccine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Vaccine Type
  • 7.3.2. France Microneedle Flu Vaccine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Vaccine Type
  • 7.3.3. United Kingdom Microneedle Flu Vaccine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Vaccine Type
  • 7.3.4. Italy Microneedle Flu Vaccine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Vaccine Type
  • 7.3.5. Spain Microneedle Flu Vaccine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Vaccine Type

8. Asia Pacific Microneedle Flu Vaccine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Vaccine Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microneedle Flu Vaccine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Vaccine Type
  • 8.3.2. India Microneedle Flu Vaccine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Vaccine Type
  • 8.3.3. Japan Microneedle Flu Vaccine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Vaccine Type
  • 8.3.4. South Korea Microneedle Flu Vaccine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Vaccine Type
  • 8.3.5. Australia Microneedle Flu Vaccine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Vaccine Type

9. Middle East & Africa Microneedle Flu Vaccine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Vaccine Type
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microneedle Flu Vaccine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Vaccine Type
  • 9.3.2. UAE Microneedle Flu Vaccine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Vaccine Type
  • 9.3.3. South Africa Microneedle Flu Vaccine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Vaccine Type

10. South America Microneedle Flu Vaccine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Vaccine Type
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microneedle Flu Vaccine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Vaccine Type
  • 10.3.2. Colombia Microneedle Flu Vaccine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Vaccine Type
  • 10.3.3. Argentina Microneedle Flu Vaccine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Vaccine Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microneedle Flu Vaccine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Debiotech S.A.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. NanoPass Technologies Limited
• 15.3. Becton, Dickinson and Company
• 15.4. FluGen, Inc.
• 15.5. CosMED Pharmaceuticals Co., Ltd.
• 15.6. Microdermics Inc.
• 15.7. TSRL Inc.
• 15.8. Vaxess Technologies Inc.
• 15.9. Pfizer, Inc.
• 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer